Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
Conditions
Interventions
Intervention1: Three drugs Ibuprofen (400 mg), Celecoxib (200 mg), and Aceclofenac (100 mg) used as a single drug therapy to treat postoperative pain.: This study compares the effectiveness of three d
Sponsors
Saveetha Dental College
Eligibility
Inclusion criteria
Inclusion criteria: The inclusion criteria for ideal implant surgery include good systemic health with controlled medical conditions, absence of active periodontal disease or oral infections, and adequate oral hygiene. Patients must have sufficient bone volume and density to support the implant, along with healthy keratinized gingiva and proper soft tissue volume. Functional factors like balanced occlusion and the absence of parafunctional habits should be considered. Candidates should be psychologically prepared, have realistic expectations, and be committed to post-operative care. Implants are typically placed in adults with completed craniofacial growth, with no upper age limit if overall health permits.
Exclusion criteria
Exclusion criteria: uncontrolled systemic diseases such as diabetes or cardiovascular conditions, active periodontal disease, or untreated oral infections. Patients with insufficient bone quantity or quality who are unwilling to undergo bone augmentation are not ideal candidates. Heavy smoking, substance abuse, or severe bruxism can compromise healing and implant stability. Poor oral hygiene, lack of commitment to post-operative care, and unrealistic expectations also pose risks. Psychological disorders, recent radiation therapy to the head and neck, and incomplete craniofacial development in growing patients are additional contraindications. Proper patient selection is essential to ensure successful implant outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of the single-drug regimen in managing postoperative pain by assessing the Summed Pain Intensity Difference (SPID) over the first 12 hours after T0 (SPID12). To calculate Total Pain Relief (TOTPAR) values over 4, 8, 12, and 24 hours after T0. To assess SPID at 4, 8, and 12 hours after T0. To determine the time to confirmed perceptible pain relief (PR) and time to meaningful PR. To record the use of rescue medication. To measure Pain Intensity Difference (PID) at various time points: 4, 8, 12, 24, 48, 72 hours after T0. To calculate the time to peak PR.Timepoint: To evaluate the efficacy of the single-drug regimen in managing postoperative pain by assessing the Summed Pain Intensity Difference (SPID) over the first 12 hours after T0 (SPID12). To calculate Total Pain Relief (TOTPAR) values over 4, 8, 12, and 24 hours after T0. To assess SPID at 4, 8, and 12 hours after T0. To determine the time to confirmed perceptible pain relief (PR) and time to meaningful PR. To record the use of rescue medication. To measure Pain Intensity Difference (PID) at various time points: 4, 8, 12, 24, 48, 72 hours after T0. To calculate the time to peak PR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of the drugs provided. Long term status of the implantTimepoint: 0-6 months | — |
Countries
India
Contacts
Public ContactVamshi Nizampuram
Saveetha Dental College
Outcome results
None listed